Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review

Date: May 30, 2017
Pages: 58
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: L8B5BC7FB63EN
Leaflet:

Download PDF Leaflet

Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review
Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Lonza Group Ltd (Lonza) is a biopharmaceutical company that manufactures and develops chemical and biological active pharmaceutical ingredients, and other products and services. The company offers active pharmaceutical ingredients, stem cell therapies, drinking water sanitizers, vitamin B compounds, industrial preservatives, microbial control solutions and organic personal care ingredients. It also provides custom development and custom manufacturing services to its clients. Lonza’s client base includes professionals in the biotechnology, pharmaceutical, academic, and government research industries; manufacturers of health and consumer products; distributors; formulators and service companies. The company’s key markets include bioresearch, nutrition, pharma and biotech, microbial control, agriculture, materials science and personal care industries. It operates several manufacturing and research and development (R&D) facilities across Asia, Europe and Americas. Lonza is headquartered in Basel, Switzerland.

Lonza Group Ltd Key Recent Developments

Feb 27,2017: Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility
Feb 10,2017: Lonza to Showcase Portfolio of Primary Cells and RAFT 3D Culture System to Support Cancer Scientists at AACR Annual Meeting
Jan 25,2017: Lonza Reports Record-Breaking Financial Performance, Resulting in 24.2% CORE EBIT Growth, Driven by Pharma and Biotech
Jan 25,2017: Lonza Appoints Fridtjof Helemann, CHRO, to Executive Committee
Sep 07,2016: Lonza Releases Second-Generation Immunogenicity Assessment and Optimization Platform for Development of Therapeutic Proteins, Vaccines and Cell Therapies

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
strong>SECTION 1 - ABOUT THE COMPANY

Lonza Group Ltd - Key Facts
Lonza Group Ltd - Key Employees
Lonza Group Ltd - Key Employee Biographies
Lonza Group Ltd - Key Operational Employees
Lonza Group Ltd - Major Products and Services
Lonza Group Ltd - History
Lonza Group Ltd - Company Statement
Lonza Group Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Lonza Group Ltd - Business Description
Lonza Group Ltd - Corporate Strategy
Lonza Group Ltd - SWOT Analysis
SWOT Analysis - Overview
Lonza Group Ltd - Strengths
Lonza Group Ltd - Weaknesses
Lonza Group Ltd - Opportunities
Lonza Group Ltd - Threats
Lonza Group Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Lonza Group Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 27, 2017: Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility
Feb 10, 2017: Lonza to Showcase Portfolio of Primary Cells and RAFT 3D Culture System to Support Cancer Scientists at AACR Annual Meeting
Jan 25, 2017: Lonza Reports Record-Breaking Financial Performance, Resulting in 24.2% CORE EBIT Growth, Driven by Pharma and Biotech
Jan 25, 2017: Lonza Appoints Fridtjof Helemann, CHRO, to Executive Committee
Sep 07, 2016: Lonza Releases Second-Generation Immunogenicity Assessment and Optimization Platform for Development of Therapeutic Proteins, Vaccines and Cell Therapies
Aug 31, 2016: Lonza to Demonstrate Capabilities in Non-Viral or Viral CAR-T Research and Manufacturing at CAR-TCR Summit
Jul 12, 2016: New e-Learning Module in the Lonza QC Insider Toolbox Helps Scientists Overcome Interference in the Bacterial Endotoxins Test
May 17, 2016: Lonza CytoSMART Lab Free-Trial Initiative Launched
May 10, 2016: Rodolfo Savitzky appointed as new CFO for Lonza to succeed Toralf Haag who was appointed as CFO of the Voith in Germany
Apr 26, 2016: Lonza Reports Record First Quarter

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Lonza Group Ltd, Key Facts
Lonza Group Ltd, Key Employees
Lonza Group Ltd, Key Employee Biographies
Lonza Group Ltd, Key Operational Employees
Lonza Group Ltd, Major Products and Services
Lonza Group Ltd, History
Lonza Group Ltd, Subsidiaries
Lonza Group Ltd, Joint Venture
Lonza Group Ltd, Key Competitors
Lonza Group Ltd, Ratios based on current share price
Lonza Group Ltd, Annual Ratios
Lonza Group Ltd, Annual Ratios (Cont.1)
Lonza Group Ltd, Annual Ratios (Cont.2)
Lonza Group Ltd, Interim Ratios
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Lonza Group Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Lonza Group Ltd, Performance Chart (2012 - 2016)
Lonza Group Ltd, Ratio Charts
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Zep Inc.
Sannitree International
Royal DSM NV
NBE-Therapeutics AG
Mabuhay Vinyl Corporation
Givaudan S.A.
Dottikon ES Holding AG
Caladrius Biosciences Inc
BASF SE
Aliancys AG
Actelion Ltd
Skip to top


Ask Your Question

Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: